Rose became acquainted with Patient Worthy after her husband was diagnosed with Acute Myeloid Leukemia (AML) six years ago. During this period of partial remission, Rose researched investigational drugs to be prepared in the event of a relapse. Her husband died February 12, 2021 with a rare and unexplained occurrence of liver cancer possibly unrelated to AML.
The Chow family was told that their 33-year-old daughter, Brittney, would have to wait about twelve years for a kidney transplant. There were currently no kidneys available for transplantation. Elizabeth…
Continue Reading
There Is No Limit to What Some Mothers Will Do For Their Children.
In March the FDA’s expert advisers voted 11 to 2 in favor of approving Roche’s antibody drug Polivy to treat lymphoma patients. According to an article in BiopharmaDive, the decision…
Continue Reading
The FDA Approves Roche’s Antibody Drug Polivy to Treat Lymphoma Patients
The safety, pharmacokinetics (absorption), and tolerability of the investigational eIF2B activator ABBV-CLS-7262 is being evaluated in a Phase 1b clinical study to treat patients with Vanishing White Matter (VWM) Disease.…
Continue Reading
ABBV CLS 7262 is Being Evaluated as a Potential Treatment for Vanishing White Matter Disease in the Brain
PhRMA Public Affairs recently carried the good news that Governor Holcomb of Indiana has joined the governors of Arkansas and West Virginia by signing a law aptly named 'Share the…
Continue Reading
Indiana Legislature Passes Bill Protecting Patients from Paying More Than Their Insurers
This week PR Newswire carried an announcement by the biotechnology company Immunic Inc. of preclinical data confirming that Vidofludimus Calcium (IMU 838) may be a Nurr 1-Activator reinforcement. Immunic is…
Continue Reading
Immunic Inc. Announces Promising Pre-Clinical Findings for Multiple Sclerosis
source: pixabay.com
For patients who were given a diagnosis of advanced, inoperable (unresectable) biliary tract cancer, an article appeared in Healio with some encouraging news. Gemcitabine and cisplatin drugs have…
Continue Reading
A Glimmer of Hope for Patients with Advanced Biliary Tract Cancer
source: pixabay.com
Omisirge (omidubicel) is the first allogeneic (from a donor) product for SCT that has been the recipient of FDA approval. The FDA's nod moves Omisirge into the realm of…
Continue Reading
New Cell Therapy Approved by the FDA to Reduce Risk of Infection After Transplant
source: shutterstock.com
The damage caused by cocaine can sometimes be misdiagnosed as a rare disease: granulomatosis with polyangiitis. Cocaine use has been increasing in America and the UK, resulting in serious…
Continue Reading
Damage from Cocaine Abuse can be Misdiagnosed as Granulomatosis with Polyangiitis
source: shutterstock.com
Compassion [kuhm-pash-uhn] noun A feeling of deep sympathy and sorrow for another who is stricken by misfortune, accompanied by a strong desire to alleviate the suffering. Compassion Corner is a…
Continue Reading
Compassion Corner: Compassion Should be Reciprocal: The Rising Suicide Rate of Physicians and Nurses
source: pixabay.com
In the last decade, NAFLD in pregnancy has nearly tripled in concert with the worldwide increase in diabetes. Mayo Clinic reports that NAFLD in general affects one-fourth of the…
Continue Reading
Non-Alcoholic Fatty Liver Disease (NAFLD) in Pregnancy has Nearly Tripled in the Past Ten Years
Gene therapy has seemed out of reach for decades. Yet advocates have considered it a way to have damaged or missing genes restore dystrophin and other proteins. Doctors and advocates…
Continue Reading
Sarepta’s Duchenne Gene Therapy Drug Cleared for Accelerated Approval
source: shutterstock.com
A Business Wire Press Release on April 26, 2023, announced positive interim clinical data on an investigational RNAi therapeutic. Alnylam Pharmaceuticals and its partner Regeneron Pharmaceuticals heralded interim results…
Continue Reading
Positive Interim Findings in Alzheimer’s Clinical Trial
Canada’s unemployment rate is at a record low. Industries have recovered 126% of the jobs lost by the pandemic. On the health front, scientific knowledge and the ability to…
Continue Reading
Canada Will Provide $1.5 Billion to Provinces to Support Rare Disease Programs
source: pixabay.com
For patients with refractory or relapsed KMT2A rearrangement or NPM1-mutations, the AUGMENT 101 study of the investigational menin inhibitor revumenib yielded impressive results. According to an article in MedicalXpress,…
Continue Reading
Advanced Leukemia: Test of Oral Revumenib Brought Impressive Results
source: shutterstock.com
Clinical trials are often mentioned as an afterthought when discussing the length of time it takes for drugs to be approved by the FDA. On the contrary, clinical trials are…
Continue Reading
Increasing Patient Engagement in Clinical Trials
Prasanna Shirol, Executive Director of the Organization for Rare Diseases India (ORDI), expresses his opinion to the Times of India about the urgency to address the issue of rare…
Continue Reading
Opinion: The Urgency to Address the Issue of Rare Diseases in India
source: pixabay.com
The FDA estimates that there are about five hundred people in the USA with the SOD1 mutation out of a total of approximately thirty thousand ALS patients. According to a…
Continue Reading
A New Medicine for ALS Patients with the SOD1 Mutation
source: pixabay.com
There is no cure for cystic fibrosis. That is the reason the Cystic Fibrosis Research Institute (CFRI) is very vocal and makes it clear that cooperation is needed from the…
Continue Reading
May is Cystic Fibrosis (CF) Month and Some Patients Are Living Past Middle Age Due to Treatment Advances
source: pixabay.com
Compassion [kuhm-pash-uhn] noun A feeling of deep sympathy and sorrow for another who is stricken by misfortune, accompanied by a strong desire to alleviate the suffering. Compassion Corner is a…
Continue Reading
Compassion Corner: An Honest Account by an Orthopedic Surgeon Who Found the Key to Compassion
source: pixabay.com
People with rare undiagnosed conditions present challenges to doctors when they are attempting to understand the root causes of their patient’s health problems. A recent article in Medical Xpress reports…
Continue Reading
A Rare Look at the Origins of Genetic Disorders: PI3K Delta Syndrome 2
source: pixabay.com
STAT NEWS recently published an op-ed with a provocative question: How do we tell the difference between legitimate mental health tech and snake oil? Looking back to the early…
Continue Reading
How Can We Tell What Mental Health Tech is Actually Effective?
Perhaps one of the most difficult challenges of families impacted by certain rare diseases is trying to appear “normal” for the sake of others in the family. That is one…
Continue Reading
Their Child Has SYNGAP1 Syndrome, Causing the Family to Face Overwhelming Challenges
source: shutterstock.com
Over the years, there has been minimal improvement in the life expectancy differences between white and black people living in the United States. Yet, according to an article featured…
Continue Reading
A New National Analysis Indicates that Higher Levels of Black Primary Care Physicians Means Longer Life Expectancy for Black Patients
The FDA has carried on a year-long disagreement with BrainStorm Cell Therapies, the developer of the experimental stem cell treatment called NurOwn. It is referred to as a personalized cell…
Continue Reading
BrainStorm Files an ALS Drug Application Despite the FDA’s Protest
source: pixabay.com
On March 22, 2023, via PRNewswire, the FDA announced that its CNS Drugs Advisory Committee voted unanimously in favor of a potential accelerated approval of tofersen to treat people with…
Continue Reading
Amyotrophic Lateral Sclerosis Drug Developers Set Their Sights on a New Treatment Target